This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parmar, K Articles by Rosenberg, N Search for Related Content PubMed PubMed Citation Articles by Parmar, K Articles by Rosenberg, N

 Previous Article  |  Next Article 

J Virol. 1991 December; 65(12): 6478-6485

Carboxyl-terminal determinants of Abelson protein important for lymphoma induction.

Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts 02111.

ABSTRACT

The carboxyl-terminal region of the Abelson protein is not absolutely required for Abelson virus transformation. However, Abelson virus strains encoding proteins missing portions of this region have a reduced ability to transform lymphoid cells in vitro and in vivo. One such strain, called P90A, is unique in that P90A-injected mice almost always develop tumors containing highly oncogenic variants that encode new forms of Abelson protein. In this work, we have examined the mechanism by which these variants are generated and used the variants to identify carboxyl-terminal protein sequences important for the induction of Abelson disease. Analysis of mice injected with helper-free P90A virus stocks demonstrates that the variants are generated during viral replication in vivo, probably as a consequence of error-prone reverse transcription. The sequence of the P90A viral genome reveals that a 19-base deletion is responsible for synthesis of the truncated Abelson protein. As a consequence of this mutation, 167 carboxyl-terminal amino acids normally found in the wild-type protein have been replaced by 33 amino acids derived from an alternative reading frame. Site-directed mutants show that the combination of the deletion and the P90A carboxyl terminus is required for the generation of variants. Thus, the particular structure of the P90A protein, not the specific residues lost or gained, alters the transforming potential of the Abelson protein. Finally, the sequence of the variants encoding smaller Abelson proteins reveals that as few as 452 v-abl-encoded amino acids are required for rapid induction of Abelson disease.

This article has been cited by other articles:

• Yi, C.-r., Rosenberg, N. (2008). Mutations Affecting the MA Portion of the v-Abl Protein Reveal a Conserved Role of Gag in Abelson Murine Leukemia Virus (MLV) and Moloney MLV. J. Virol. 82: 5307-5315 [Abstract] [Full Text]  
• Yi, C.-R., Rosenberg, N. (2007). Gag Influences Transformation by Abelson Murine Leukemia Virus and Suppresses Nuclear Localization of the v-Abl Protein. J. Virol. 81: 9461-9468 [Abstract] [Full Text]  
• Marchlik, E., Kalman, R., Rosenberg, N. (2005). Decreased Virus Population Diversity in p53-Null Mice Infected with Weakly Oncogenic Abelson Virus. J. Virol. 79: 11618-11626 [Abstract] [Full Text]  
• Warren, D., Griffin, D. S., Mainville, C., Rosenberg, N. (2003). The Extreme Carboxyl Terminus of v-Abl Is Required for Lymphoid Cell Transformation by Abelson Virus. J. Virol. 77: 4617-4625 [Abstract] [Full Text]  
• Zou, X., Cong, F., Coutts, M., Cattoretti, G., Goff, S. P., Calame, K. (2000). p53 Deficiency Increases Transformation by v-Abl and Rescues the Ability of a C-Terminally Truncated v-Abl Mutant To Induce Pre-B Lymphoma In Vivo. Mol. Cell. Biol. 20: 628-633 [Abstract] [Full Text]  
• Unnikrishnan, I., Radfar, A., Jenab-Wolcott, J., Rosenberg, N. (1999). p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells. Mol. Cell. Biol. 19: 4825-4831 [Abstract] [Full Text]  
• Shi, Y, Alin, K, Goff, S P (1995). Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity.. Genes Dev. 9: 2583-2597 [Abstract]